Dr. Shuhao Wen is the co-founder and chairman of the board at XtalPi, and an adjunct professor at Zhejiang University. Shuhao is a published quantum physicist with over 14 years of research experiences on multi-scale simulation technology, quantum-classical hybrid theory, and molecular crystal polymorphism ranking theory. Prior to founding XtalPi, Shuhao completed his postdoctoral research at the Massachusetts Institute of Technology (MIT) and worked as a postdoctoral research scholar at the University of California at Riverside. At UC Riverside, he participated in the development of the HMBI (Hybrid Many Body Interaction) approach, a highly accurate calculation model for molecular crystal. Shuhao has published 32 papers and is the holder of 5 patents and 3 PCT patents. He led the development and industrial application of XtalPi’s crystal structure prediction algorithm, which is an important technological advancement in this field.

Shuhao holds a Ph.D. in sciences from Chinese Academy of Sciences.

Jian Ma, Ph.D., is co-founder and CEO of XtalPi, overseeing business operations as well as research and product development. Prior to founding XtalPi in 2014, Dr. Ma served as a postdoctoral associate at the Massachusetts Institute of Technology, and was visiting scholar at RIKEN in Japan and The Chinese University of Hong Kong, during which time he completed extensive research on quantum information, quantum computing, and numerical simulation. Dr. Ma has published over twenty peer-reviewed articles on top scholarly publications, including Physics Reports, Physical Reiview and Journal of Chemical Physics.

Dr. Ma earned his doctorate and B.S. in Physics at Zhejiang University.

Lipeng has a diverse background in mathematics and physics, including particle physics, fluid dynamics, biophysics and complex networks. As XtalPi’s co-founder, he is currently leading the company’s Beijing team, which is focusing on the application of AI technologies in the development of new therapeutics. By integrating big data from biology and chemistry with deep learning algorithms, XtalPi aims to provide solutions that can e actively accelerate drug discovery. The team is also seeking in-depth collaboration projects with researchers to explore the potential of AI in fundamental research areas such as biology and chemistry.

Lipeng received his double B.S. degree in physics and mathematics from Peking University and his Ph.D. in physics from the University of Chicago. He was a SUTD- MIT graduate fellow at MIT when he co-founded XtalPi.